Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4865 - 4872 of 11617 results
FRAND Licensing of Global Portfolios – Who Gets to Set Worldwide Rates?
March 26, 2019| Blog| Viewpoint
Brexit and UK-US data transfers: What’s the plan?
March 26, 2019| Blog| Viewpoint
ML Strategies Health Care Preview - Week of March 25, 2019
March 26, 2019| Blog| Viewpoint
Can I Raise Venture Capital as a Public Benefit Corporation?
March 25, 2019| Blog| Viewpoint
Third Time’s Not the Charm: Supreme Court Again Declines to Weigh in on Escobar’s “Materiality” Standard
March 25, 2019| Blog| Viewpoint
Arbitration Law And Jury Demands: Devil Is In The Details
March 25, 2019| News
Can I Raise Venture Capital as a Public Benefit Corporation?
March 25, 2019| News
Mintz Grabs Perkins Coie White-Collar Partner in San Diego
March 25, 2019| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.